HIA Sainte Anne
- Address
- lock Available on a paid plan
HIA Sainte Anne - Thoracic Oncology and Multi-Specialty Research Center
HIA Sainte Anne is a distinguished military medical research institution with exceptional expertise in thoracic oncology, particularly non-small cell lung cancer (NSCLC). The center demonstrates advanced capabilities in investigating novel immunotherapies, targeted therapies, and combination treatment strategies across various stages of lung cancer, from early resectable disease to advanced metastatic presentations.
- Non-Small Cell Lung Cancer: Comprehensive research portfolio spanning neoadjuvant/adjuvant immunotherapy, PD-L1 targeted therapies, ALK/ROS1 biomarker-driven treatments, and perioperative care strategies
- Infectious Disease and Orthopedic Infections: Specialized studies in prosthetic joint infections and antibiotic prophylaxis for burn surgery, emphasizing military-relevant trauma care
- Immunologic and Dermatologic Conditions: Investigation of novel biologics for chronic spontaneous urticaria, atopic dermatitis, hidradenitis suppurativa, and HPV-related conditions
- Neurological and Hematological Disorders: Research in multiple sclerosis, ischemic stroke interventions, and multiple myeloma treatment regimens
The center's participation in landmark international trials, including IMpower010, KEYLYNK studies, and precision medicine platforms, underscores its commitment to advancing personalized cancer care. HIA Sainte Anne's involvement in diverse therapeutic areas—from cardiovascular atherosclerosis prevention to gastrointestinal malignancies—reflects its comprehensive research infrastructure and multidisciplinary approach to clinical investigation, particularly serving military and civilian populations with complex medical needs.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 13 therapeutic areas and 15 of 110 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 109 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 16 by active trials.
- 1AstraZeneca AB6active
lock +15 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB9trials
lock +12 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in HIA Sainte Anne
lock Showing 1 of 66 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 110 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 21 | Unknown | 2018-04-04 | 2025-09-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.